Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 32,804,000 | 0 | 29,559,000 | 26,475,000 | 23,950,000 |
| Cost of Goods | 5,775,000 | N/A | 6,419,000 | 5,559,000 | 5,356,000 |
| Gross Profit | 27,029,000 | 25,003,000 | 23,140,000 | 20,916,000 | 18,594,000 |
| Operating Expenses | 15,486,000 | 5,179,000 | 15,774,000 | 13,785,000 | 12,285,000 |
| Operating Income | 11,543,000 | -5,179,000 | 7,366,000 | 7,131,000 | 6,309,000 |
| Other Income | -736,000 | 0 | 617,000 | 1,412,000 | 358,000 |
| Pre-tax Income | 10,807,000 | -5,179,000 | 7,983,000 | 8,543,000 | 6,667,000 |
| Income Tax | 3,263,000 | N/A | 2,356,000 | 2,480,000 | 1,943,000 |
| Net Income Continuous | 7,544,000 | 6,130,000 | 5,894,000 | 6,063,000 | 4,724,000 |
| Net Income | $7,544,000 | $6,130,000 | $5,595,000 | $6,063,000 | $4,724,000 |
| EPS Basic Total Ops | 2.60 | 2.10 | 1.87 | 1.93 | 1.46 |
| EPS Basic Continuous Ops | 2.61 | 2.11 | 1.97 | 1.94 | 1.46 |
| EPS Diluted Total Ops | 2.60 | 2.10 | 1.87 | 1.93 | 1.46 |
| EPS Diluted Continuous Ops | 2.60 | 2.11 | 1.97 | 1.93 | 1.46 |
| EBITDA(a) | $13,630,000 | $-2,559,000 | $9,222,000 | $8,476,000 | $7,636,000 |